Back to Blog

Compound Profiles

GLP-1 Receptor Agonists: A Research Overview of Semaglutide, Tirzepatide & Retatrutide

Healthy Aminos Research Team · · 8 min read

The GLP-1 Pathway

Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by intestinal L-cells in response to nutrient ingestion. GLP-1 receptor agonists bind to the GLP-1R, a class B G-protein coupled receptor expressed in pancreatic beta cells, the central nervous system, and other tissues.

Research interest in GLP-1 receptor agonists has expanded significantly following multiple large-scale clinical trial programs.

Semaglutide

Semaglutide is a 31-amino acid GLP-1 receptor agonist with two key structural modifications: an Aib substitution at position 8 (protecting against DPP-4 degradation) and a C-18 fatty diacid linker at position 26 (enabling albumin binding for half-life extension to approximately 7 days).

Published data from the SUSTAIN, PIONEER, and STEP trial programs — involving over 20,000 participants — have been extensively documented in peer-reviewed journals.

Tirzepatide

Tirzepatide is a 39-amino acid dual GIP/GLP-1 receptor agonist. Its mechanism engages both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor simultaneously. Published data from the SURPASS and SURMOUNT programs have documented dose-dependent responses across metabolic parameters.

The SURPASS-2 trial represents the only head-to-head comparison with semaglutide published to date.

Retatrutide

Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors. Early phase clinical results published in the New England Journal of Medicine showed dose-dependent metabolic responses. The glucagon receptor component adds thermogenic and lipolytic signaling pathways not present in GLP-1-only or dual-agonist compounds.

Molecular Comparison

All three compounds share the fundamental GLP-1R agonist mechanism but differ in receptor selectivity profile, fatty acid modifications for half-life extension, and the number of receptor targets engaged.

GLP-1semaglutidetirzepatideretatrutidemetabolic

Related Compound

Semaglutide Peptide

10mg · ≥98% · From $44.99

View Semaglutide \u2192

Research Use Only

FOR RESEARCH USE ONLY. Products sold by Healthy Aminos are intended strictly for in-vitro research and laboratory use. Not for human or animal consumption. Not FDA approved. By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold as reference standards and research chemicals only.